journal article·2026-06

Stem Cell‐Laden Magnetic Hydrogels for Liver Fibrosis Reversal via Synergistic Magneto‐Mechanical Stimulation

Haoyang Ding, Jiaxiang Li, Zhen Chen, Xiangchuan Xu, Lili Hao, Lingyun Sun, Zhongwei Gu, Hongli Mao

Advanced Functional Materials· Volume 36· Issue 44
Publisher page

Abstract

ABSTRACT As a critical stage in chronic liver disease, liver fibrosis can progress to irreversible damage without timely intervention. Stem cell therapy offers significant therapeutic potential owing to its potent regenerative and immunomodulatory properties. However, its clinical application is challenged by low cell survival, poor targeting, and inadequate paracrine regulation. Here, we present a magnetic hydrogel patch laden with human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs) to enhance their antifibrotic efficacy via synergistic magneto‐mechanical stimulation. The patch is fabricated through thiol‐ene “click” chemistry using multi‐thiol‐functionalized magnetic nanoparticles as crosslinkers. Molecular dynamics simulations reveal the regulatory mechanism of nanoparticle concentration on the crosslinking topology of the hydrogel network, thereby identifying the optimal formulation with favorable mechanical properties and magnetic responsiveness. Under magneto‐mechanical stimulation, the resulting patch significantly enhances the secretion of key antifibrotic factors from hUC‐MSCs by activating the PI3K/Akt/mTOR signaling pathway. Moreover, in vitro and in vivo results demonstrate that, under magnetic stimulation, the hUC‐MSC‐laden magnetic patch significantly inhibits hepatic stellate cell activation, promotes anti‐inflammatory macrophage polarization, reduces collagen deposition, and ameliorates the inflammatory microenvironment, thereby effectively reversing liver fibrosis. This study offers a versatile stem cell‐based platform for spatiotemporally controlled therapy of liver fibrosis and potentially other fibrotic diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Hepatocellular Carcinoma Treatment and Prognosis · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Institute for Biomaterials Tech Institute for Advanced Materials Bio‐inspired Biomedical Materials & Devices Center College of Materials Science and Engineering Jiangsu Collaborative Innovation Center for Advanced Inorganic Function Composites Suqian Advanced Materials Industry Technology Innovation Center Nanjing Tech University Nanjing China

National Laboratory of Solid State Microstructures and School of Physics Collaborative Innovation Center of Advanced Microstructures Nanjing University Nanjing China

Department of Rheumatology and Immunology Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University Nanjing China

Funding

National Key Research and Development Program of China · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1038/s41575‐023‐00807‐x10.1038/s41575‐023‐00807‐x ↗
2. 10.1038/s41575‐023‐00821‐z10.1038/s41575‐023‐00821‐z ↗
3. 10.1038/s41575‐020‐00372‐710.1038/s41575‐020‐00372‐7 ↗
4. 10.1002/advs.20230012710.1002/advs.202300127 ↗
5. 10.1016/j.jconrel.2024.02.02210.1016/j.jconrel.2024.02.022 ↗
6. 10.1016/j.jhep.2022.08.02110.1016/j.jhep.2022.08.021 ↗
7. 10.1016/j.biomaterials.2017.11.02710.1016/j.biomaterials.2017.11.027 ↗
8. 10.1186/s13287‐022‐03041‐510.1186/s13287‐022‐03041‐5 ↗
9. 10.1038/s41392-022-00932-010.1038/s41392-022-00932-0 ↗
10. 10.1016/j.addr.2022.11430010.1016/j.addr.2022.114300 ↗
11. 10.1084/jem.2019040210.1084/jem.20190402 ↗
12. 10.1053/j.gastro.2016.12.00310.1053/j.gastro.2016.12.003 ↗
13. 10.7150/thno.4543410.7150/thno.45434 ↗
14. 10.1126/sciadv.adq070310.1126/sciadv.adq0703 ↗
15. 10.1126/sciadv.adn522810.1126/sciadv.adn5228 ↗
16. 10.1126/scitranslmed.aba456410.1126/scitranslmed.aba4564 ↗
17. 10.1038/s41423‐023‐00983‐510.1038/s41423‐023‐00983‐5 ↗
18. 10.1016/j.compositesb.2023.11071110.1016/j.compositesb.2023.110711 ↗
19. 10.1016/j.biomaterials.2023.12245110.1016/j.biomaterials.2023.122451 ↗
20. 10.1016/j.stem.2015.12.00410.1016/j.stem.2015.12.004 ↗
21. 10.1039/D2NR06233J10.1039/D2NR06233J ↗
22. 10.1002/advs.20220227810.1002/advs.202202278 ↗
23. 10.1016/j.jconrel.2021.06.00310.1016/j.jconrel.2021.06.003 ↗
24. 10.1126/sciadv.aaz095210.1126/sciadv.aaz0952 ↗
25. 10.1021/acs.chemrev.0c0092310.1021/acs.chemrev.0c00923 ↗
26. 10.1016/j.biomaterials.2020.12053010.1016/j.biomaterials.2020.120530 ↗
27. 10.1021/acsami.3c0068810.1021/acsami.3c00688 ↗
28. 10.1016/j.jmst.2023.10.03010.1016/j.jmst.2023.10.030 ↗
29. 10.1039/b919449p10.1039/b919449p ↗
30. Doi M. · 1988
31. Hansen J.‐P. · 2013
32. 10.1016/j.phymed.2024.15546510.1016/j.phymed.2024.155465 ↗
33. 10.3892/ijmm.2020.477810.3892/ijmm.2020.4778 ↗
34. 10.3389/fimmu.2015.0010110.3389/fimmu.2015.00101 ↗
35. 10.1016/j.ebiom.2019.07.00910.1016/j.ebiom.2019.07.009 ↗
36. 10.3748/wjg.v21.i3.74210.3748/wjg.v21.i3.742 ↗
37. 10.1016/j.coph.2008.08.00410.1016/j.coph.2008.08.004 ↗
38. 10.1002/advs.20230899310.1002/advs.202308993 ↗
39. 10.1039/D5MH00930H10.1039/D5MH00930H ↗
40. 10.1016/j.bioactmat.2025.02.03210.1016/j.bioactmat.2025.02.032 ↗
41. 10.1111/j.1478‐3231.2005.01192.x10.1111/j.1478‐3231.2005.01192.x ↗
42. 10.1016/j.kint.2021.09.03310.1016/j.kint.2021.09.033 ↗
43. 10.1002/hep.2045210.1002/hep.20452 ↗
44. 10.1038/s41418‐021‐00871‐310.1038/s41418‐021‐00871‐3 ↗
45. 10.1016/j.phymed.2020.15329410.1016/j.phymed.2020.153294 ↗
46. 10.3390/cells811141910.3390/cells8111419 ↗
47. 10.3390/cells1010275910.3390/cells10102759 ↗
48. Macrophage in Liver Fibrosis: Identities and Mechanisms
49. 10.1002/adhm.20250076110.1002/adhm.202500761 ↗
50. 10.1002/adma.20240853810.1002/adma.202408538 ↗
51. 10.1002/adfm.20250072610.1002/adfm.202500726 ↗
52. 10.1021/acsami.4c2013110.1021/acsami.4c20131 ↗
53. 10.1002/adhm.20220108510.1002/adhm.202201085 ↗